AFT — AFT Pharmaceuticals Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareBalancedSmall CapNeutral

Annual balance sheet for AFT Pharmaceuticals, fiscal year end - March 31st, NZD millions except per share, conversion factor applied.

	2021 March 31st	R2022 March 31st	2023 March 31st	2024 March 31st	2025 March 31st
Period Length:	—	—	—	—	—
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Cash and Short Term Investments	3.21	7.94	4.75	12	11.1
Net Total Accounts Receivable
Net Total Receivables	29.2	29.9	39.6	41	43.2
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	67.9	77.5	94.6	106	108
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	3.79	3.36	3.37	3.82	3.25
Net Intangible Assets
Other Long Term Assets
Total Assets	105	127	148	165	170
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	32.1	29.1	39.8	46.1	43.3
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Minority Interest
Total Liabilities	68.5	65	74.8	77.5	72.2
Redeemable Preferred Stock
Common Stock
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	36.6	62.3	73.3	87.8	97.6
Total Liabilities & Shareholders' Equity	105	127	148	165	170
Total Common Shares Outstanding